AMP Step Wedge Trial (AMP SWT)

April 23, 2024 updated by: Johns Hopkins University

Activity and Mobility Promotion (AMP): Implementation and Impact of a Multifaceted Intervention to Increase Mobility in Hospital Patients

Annually, more than 35 million patients are hospitalized in the United States. Many of these will experience hospital-acquired loss of physical functioning due to a lack of mobility during their in-patient stay. Such loss includes difficulties performing basic activities, such as rising from a chair, toileting, or ambulating. This loss of function may increase hospital length of stay (LOS), nursing home placement, and decrease mobility and participation in community activities even years after hospitalization. Prevention of this hospital-acquired functional loss is critical. Even the sickest hospitalized patients (e.g., those in the intensive care unit [ICU]), can safely and feasibly benefit from early mobilization. In the non-ICU setting there is evidence that patient mobilization reduces LOS and hospital costs, while improving patient satisfaction and physical and psychological outcomes. The overall objective of this proposed project is to evaluate the implementation and impact of a transdisciplinary and multifaceted mobility program (Johns Hopkins Activity and Mobility Promotion - AMP) on clinical outcomes among hospitalized adults. In addition to clinical outcomes, we will identify barriers and facilitators to high-performance program adoption. Results of this project will provide critical new insights on the effectiveness of AMP and inform dissemination and implementation nationwide.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

16676

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21287
        • Johns Hopkins Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • All adult patients admitted to study hospital unit
  • Analysis will only include those with lengths of stay >=3 days

Exclusion Criteria:

  • Patients with active do-not-resuscitate (DNR) order
  • <18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AMP Implementation
Each study site will implement the Johns Hopkins AMP program at different times. The AMP program includes nursing staff training on the goals of AMP, how to complete mobility-focused outcome measures, set mobility goals, and to safely mobilize/ambulate patients. The AMP program also includes embedding these outcome measures and mobility goals into electronic medical records and producing weekly/monthly reports that show how often nursing staff score patient mobility and help patients meet daily activity goals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
% of patients meeting daily mobility goal
Time Frame: 39 months
Mobility goal is set and measured using the Johns Hopkins Highest Level of Mobility (JH-HLM) Scale
39 months
% of patients with mobility measurements documented daily
Time Frame: 39 months
Mobility documentation to include Activity Measure for Post-Acute Care (AM-PAC) and JH-HLM
39 months
% of patients receiving physical and/or occupational therapy consults
Time Frame: 39 months
To be extracted from electronic medical record
39 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital length of stay (days)
Time Frame: 39 months
To be extracted from electronic medical record
39 months
Discharge disposition status
Time Frame: 39 months
Count of where patients are discharged to (e.g,. home, inpatient rehab unit) assessed by extraction from electronic medical record.
39 months
Number of physical and occupational therapy visits received during inpatient stay
Time Frame: 39 months
To be extracted from electronic medical record
39 months
Number of hospital-acquired morbidities
Time Frame: 39 months
Includes falls, pressure injury, and venous thromboembolism. To be extracted from electronic medical record
39 months
Number of patients with 30-day readmissions
Time Frame: 39 months
To be extracted from electronic medical record
39 months
Employee injuries resulting from patient mobilization
Time Frame: 39 months
Number of employee injuries from facilitating patient mobility as assessed by medical record extraction
39 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sapna Kudchadkar, MD, Johns Hopkins University
  • Principal Investigator: Erik Hoyer, PhD, Johns Hopkins University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Actual)

April 1, 2024

Study Completion (Actual)

April 1, 2024

Study Registration Dates

First Submitted

August 16, 2021

First Submitted That Met QC Criteria

August 24, 2021

First Posted (Actual)

August 25, 2021

Study Record Updates

Last Update Posted (Actual)

April 25, 2024

Last Update Submitted That Met QC Criteria

April 23, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00270215

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disability

Clinical Trials on AMP Implementation

Subscribe